| Financial Year |
March 31 2023 |
| Monetary Funds |
31,530,436.99 |
| Held-for-trading Financial Assets |
-- |
| Notes Receivable |
163,914.93 |
| Accounts Receivable |
240,877,895.52 |
| Advances to Suppliers |
5,192,261.72 |
| Other Receivables |
3,099,263.69 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
380,046,257.52 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
14,339,894.13 |
| Total Current Assets |
688,253,537.76 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
282,874.86 |
| Investment Properties |
-- |
| Fixed Assetes |
25,252,337.44 |
| Under-construction Projects |
144,178,453.37 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
18,519,479.77 |
| R&D expenses |
-- |
| Goodwill |
-- |
| Long-Term Deferred and Prepaid Expenses |
1,785,470.92 |
| Deferred Income Tax Assets |
129,988.24 |
| Other Non-Current Assets |
2,742,145.86 |
| Sub-Total of Non-Current Assets |
201,537,085.64 |
| Total Assets |
889,790,623.40 |
| Short-Term Loans |
25,723,029.70 |
| Trading Financial liabilities |
-- |
| Notes Payable |
69,375,182.55 |
| Accounts Payable |
188,973,218.71 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
10,948,142.38 |
| Taxes Payable |
394,522.97 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
4,105,180.84 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
3,894,292.99 |
| Other Current Liabilities |
2,842,360.84 |
| Sub-Total of Current Liabilities |
335,918,745.24 |
| Long-term Loans |
-- |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
5,398,226.74 |
| Deferred Income Tax Liabilities |
-- |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
7,845,261.11 |
| Total Liabilities |
343,764,006.35 |
| Paid-In Capital(Or Share Stock) |
64,032,436.00 |
| Capital Surplus |
352,251,139.19 |
| Surplus Reserve |
17,363,997.38 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
112,045,401.84 |
| Minority Stockholder's Interest |
333,642.64 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
545,692,974.41 |
| Owner's Equity（Stockholder's Equity） |
546,026,617.05 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
889,790,623.40 |
